Source: International Congress 2014 – Novel approaches to human studies in allergy and asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Wenzel, D. Chantry, C. Eberhardt, R. Hopkins, M. Saunders, L. Anderson, R. Aitchinson, S. Bell, K. Izuhara, J. Ono, L. Burgess (Pittsburgh, Boulder, United States Of America; Saga, Tokyo, Japan). ARRY-502, a potent, selective, oral CRTh2 antagonist reduces Th2 mediators in patients with mild to moderate Th2-driven asthma. Eur Respir J 2014; 44: Suppl. 58, 4836

Member's Comments

No comment yet.

Related content which might interest you: Low level laser in monotherapy or in combination with leukotriene receptor antagonists in the treatment of allergic lung inflammation Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects Year: 2015 Characterization QAW039 and QAV680, two novel, potent and selective CRTh2 antagonists Source: International Congress 2014 – Allergy and asthma: novel findings based on human cell biology Year: 2014 TLR-3 triggered exacerbation of experimental asthma depends on IL-17 producing NK cells Source: International Congress 2014 – TH17 and other acute asthmatic responses Year: 2014 TLR 7/8 agonist resiquimod alleviates murine allergic asthma through IL-27 production and up regulation of B7-H1 on antigen presenting cells Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions Year: 2015 Eosinophilic airway inflammation is associated with increased TLR2 and TLR4 expression in adult asthmatics Source: International Congress 2014 – TH17 and other acute asthmatic responses Year: 2014 Schistosome-induced pulmonary B cells inhibit allergic airway inflammation and display a reduced Th2-driving function Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions Year: 2015 GARP reduces inflammation in a humanized mouse model of allergic airway disease Source: International Congress 2015 – Advances in asthma and allergy in animal models Year: 2015 LATE-BREAKING ABSTRACT: Effects of a dual CysLT1/2 antagonist, ONO-6950, on allergen-induced airway responses in subjects with mild allergic asthma. Source: International Congress 2014 – Latest insights in airway diseases Year: 2014 Osteopontin binds and modulate the antibacterial action of eosinophil-recruiting chemokines during allergic inflammation Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015 Aspirin hypersensitive and aspirin-tolerant eosinophilic asthma share common patern of inflammatory cells influx and lipid mediators in airways Source: International Congress 2014 – Asthma: clinical problems Year: 2014 D-tryptophan influences allergic airway inflammation and Th2 immune responses Source: International Congress 2015 – Asthma mechanisms and management Year: 2015 An antedrug of the CXCL12 neutraligand blocks experimental allergic asthma without systemic effect in the mouse Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD Year: 2013 Elevated IL-17A in very severe COPD is localized to mast cells and correlates with lung function decline Source: International Congress 2014 – TH17 and other acute asthmatic responses Year: 2014 QAW039, a slowly dissociating CRTh2 antagonist with potential for improved clinical efficacy Source: International Congress 2014 – Allergy and asthma: novel findings based on human cell biology Year: 2014 Levels of cytokines, sCD31 and expression of CD38 in patients with bronchial asthma of various severity out of a disease exacerbation Source: International Congress 2014 – Biomarkers of asthma and clinical immunology Year: 2014 TLR7 and TLR9-activated inflammation is differentially regulated in asthma Source: Annual Congress 2013 –Asthma Year: 2013 LATE-BREAKING ABSTRACT: TSLP as a potent activator of Th2 response in obstructive lung diseases Source: International Congress 2016 – Novel mechanisms and therapeutic targets in acute and chronic inflammatory disease Year: 2016 The effect of the novel SHIP1 activator AQX-1125 on allergen-induced responses in mild to moderate asthma Source: Annual Congress 2013 –New drugs in respiratory medicine Year: 2013 The homologous IL-17 cytokines A and F differentially regulate allergic asthma in murine models Source: International Congress 2015 – Advances in asthma and allergy in animal models Year: 2015 Novel, highly potent and selective JAK3 inhibitor disrupting IL-4/IL-13 signaling in asthma therapy Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015